Long‐term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis
暂无分享,去创建一个
H. Hönigsmann | P. V. D. van de Kerkhof | R. Roelandts | E. Schöpf | C. Griffiths | J. Berth-Jones | R. Marks | P. Harrison | C. Trompke | J. Berth‐Jones
[1] P. Harrison. Topical tacalcitol treatment for psoriasis. , 2000, Hospital Medicine.
[2] H. DeLuca,et al. Current understanding of the molecular actions of vitamin D. , 1998, Physiological reviews.
[3] P. C. van de Kerkhof. An Update on Vitamin D3 Analogues in the Treatment of Psoriasis , 1998, Skin Pharmacology and Physiology.
[4] S. Iqbalb,et al. The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis , 1997 .
[5] N. Veien,et al. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double‐blind trial , 1997, The British journal of dermatology.
[6] T. Luger,et al. Long-term efficacy and safety of once daily treatment of chronic plaque psoriasis with tacalcitol ointment , 1997 .
[7] K. Kragballe,et al. Vitamin D3 analogues. , 1997, Clinics in dermatology.
[8] T. Luger,et al. Tacalcitol ointment in the treatment of psoriasis vulgaris:a multicentre, placebo‐controlled, double‐blind study on efficacy and safety , 1996, The British journal of dermatology.
[9] K. Goa,et al. Calcipotriol: A Review of its Pharmacological Properties and Therapeutic Efficacy in the Management of Psoriasis , 1996 .
[10] C. Scarpa. Tacalcitol ointment is an efficacious and well tolerated treatment for psoriasis , 1996 .
[11] P. Hutchinson,et al. High dose topical calcipotriol consistently reduces serum parathyroid hormone levels , 1994, Clinical endocrinology.
[12] J. Bourke,et al. Urine calcium excretion during treatment of psoriasis with topical calcipotriol , 1993, The British journal of dermatology.
[13] K. Matsumoto,et al. Effect of 1,24R‐dihydroxyvitamin D3 on the Growth of Human Keratinocytes , 1990, Journal of dermatology (Print).
[14] W. Cunliffe,et al. A double‐blind, placebo‐controlled trial of topical 1,25‐dihydroxycholecalciferol in psoriasis , 1989, The British journal of dermatology.
[15] J. Berth-Jones,et al. The emergence of vitamin D as a first-line treatment for psoriasis , 1998 .
[16] P. Kerkhof. An Update on Vitamin D3 Analogues in the Treatment of Psoriasis , 1998 .
[17] H. Gollnick,et al. Current experience with tacalcitol ointment in the treatment of psoriasis. , 1998, Current medical research and opinion.
[18] P. C. van de Kerkhof,et al. A long-term assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis , 1996 .
[19] O. Baadsgaard,et al. Optimal concentration of tacalcitol in once-daily treatment of psoriasis , 1995 .
[20] W. Cunliffe,et al. Long-term use of topical calcipotriol in chronic plaque psoriasis. , 1994, Dermatology.
[21] S. Nishiyama,et al. Topical 1α, 24(R)-dihydroxyvitamin D3 for the treatment of psoriasis. Review of the literature , 1993 .
[22] Anthony W. Norman,et al. Vitamin D : gene regulation, structure-function analysis, and clinical application : proceedings of the Eighth Workshop on Vitamin D, Paris, France, July 5-10, 1991 , 1991 .
[23] J. Dry,et al. Vitamin D in dermatology. , 1990 .
[24] T Fredriksson,et al. Severe psoriasis--oral therapy with a new retinoid. , 1978, Dermatologica.
[25] J. Krafka. A simple treatment for psoriasis. , 1936 .